SCHEMBL10024286

SCHEMBL10024286

Cc1ccc(-c2ccc(Cl)cc2Cl)cc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.55
ALDH1A1 P00352 1/20 0.51
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
CASP1 P29466 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MARS1 P56192 5/20 0.48
EIF4E P06730 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
FABP4 P15090 1/20 0.46
MYC P01106 1/20 0.45
NR4A1 P22736 1/20 0.45
NOTUM Q6P988 1/20 0.44
MCL1 Q07820 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL402387 0.85 ALDH1A1 (0.63) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL28840070 0.84 ALDH1A1 (0.55) SRD5A2ALDH1A1TP53TSHRCASP1
SCHEMBL412559 0.83 CA1 (0.71) SRD5A2ALDH1A1TP53TSHRCASP1
SCHEMBL10024259 0.83 MCL1 (0.56) ALDH1A1EIF4EFABP4MCL1AKR1C2
SCHEMBL10024251 0.82 MCL1 (0.54) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL21857416 0.78 TSHR (0.56) SRD5A2ALDH1A1TP53TSHRCASP1
SCHEMBL28157812 0.78 AHR (0.53) SRD5A2TP53SMN1; SMN2MARS1NPC1
SCHEMBL10024258 0.78 DCLRE1B (0.57) NOTUMMCL1AKR1C2AKR1C1
SCHEMBL4602039 0.77 TSHR (0.52) SRD5A2ALDH1A1TP53TSHRCASP1
SCHEMBL70164 0.77 MCL1 (0.66) ALDH1A1MCL1AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083471-A1 Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same FAS SECURED CREDITORS HOLDCO, LLC 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083471-A1 Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same LCAT, DGAT2, SOAT2 SRD5A2 712/4885ALDH1A1 1533/4885TP53 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.